文献速递临床试验与 GCP组学、生物样本库与精准医学

可溶性膳食纤维对妊娠期糖尿病糖脂代谢的影响:随机对照临床试验研究方案

Effects of soluble dietary fiber on glycolipid metabolism in gestational diabetes mellitus: study protocol for a randomized controlled clinical trial.
PubMed 文献 · Trials · 2025-09-24

本研究为8周、平行设计、开放标签、三臂、单中心随机对照试验,纳入24至28周经口服葡萄糖耐量试验诊断为妊娠期糖尿病的孕妇,比较单纯营养教育、营养教育联合低剂量(12克/天)或高剂量(24克/天)木糖低聚糖与菊粉补充对糖脂代谢及肠道菌群的影响,主要结局为糖化血清蛋白变化。

要点

  • 纳入24至28周经OGTT诊断的妊娠期糖尿病孕妇,干预8周。
  • 三组分别为单纯营养教育、营养教育联合XOS菊粉12克/天或24克/天。
  • 主要结局为糖化血清蛋白变化,同时分析肠道菌群变化。

核心结论

  • 本研究旨在评估每日补充木糖低聚糖与菊粉对妊娠期糖尿病患者糖脂代谢的影响,并通过肠道菌群分析探讨治疗机制。
  • 研究还将评估补充XOS菊粉对妊娠期糖尿病患者及其子代胃肠功能和围产结局的治疗效果。
  • 研究提供肠道微生物组作为增强妊娠期糖尿病新兴治疗疗效靶点的潜在作用见解。

研究设计与样本

  • 本研究为8周、平行设计、开放标签、三臂、单中心随机对照试验。
  • 纳入标准为妊娠24至28周、经口服葡萄糖耐量试验诊断为妊娠期糖尿病的孕妇。
  • 三组分别接受单纯营养教育、营养教育联合XOS菊粉(木糖低聚糖2克与菊粉10克)12克/天、或营养教育联合XOS菊粉24克/天。
  • 测量时间点为基线、第4周和第8周。
  • 主要结局为糖化血清蛋白变化,关键次要结局包括空腹血糖、空腹胰岛素、餐后2小时血浆葡萄糖、HbA1c、总胆固醇、甘油三酯、LDL胆固醇、HDL胆固醇及肠道菌群变化。

临床怎么用

  • 所有参与者将接受全面的妊娠期糖尿病营养教育,以促进可持续的饮食调整,优化母亲代谢健康和胎儿结局。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Accumulating evidence suggests that additional dietary fiber supplements may significantly improve glycolipid metabolism and pregnancy outcomes in individuals with gestational diabetes mellitus (GDM). However, the therapeutic effects of xylose oligosaccharides and inulin (XOS inulin) in pregnant women have not been investigated. Moreover, the underlying mechanism behind the therapeutic effects of this type of dietary fiber is not clear. Our study aims to assess the effects of daily XOS inulin supplementation on glycolipid metabolism and elucidate the therapeutic mechanism through gut microbiota analysis. METHODS: This study is an 8-week, parallel-design, open-label, three-arm, single-center randomized controlled trial. Eligible participants were pregnant women between 24 and 28 weeks of gestation, and they were diagnosed with GDM through an oral glucose tolerance test (OGTT). The participants in the three groups will receive nutrition education alone, nutrition education plus XOS inulin (XOS 2 g and inulin 10 g) 12 g/day, or nutrition education plus XOS inulin 24 g/day. Measurements will be taken at baseline, week 4, and week 8. The primary outcome will be the change in glycosylated serum protein (GSP), and the key secondary outcomes include changes in fasting glucose, fasting insulin (FINS), 2-h postprandial plasma glucose (2 h-PPG), HbA1c, total cholesterol (TC), triglycerides (TG), LDL cholesterol (LDL-C), HDL cholesterol (HDL-C), and changes in the gut microbiota. DISCUSSION: This study will evaluate the therapeutic effects of XOS inulin supplementation on glycemic control, lipid metabolism, gastrointestinal function, and perinatal outcomes in GDM patients and their offspring. It also provides insight into the potential role of the gut microbiome as a target for enhancing the therapeutic efficacy of emerging treatments for GDM. All participants will receive comprehensive GDM nutrition education, promoting sustainable dietary modifications that optimize maternal metabolic health and fetal outcomes. TRIAL REGISTRATION: Chinese Clinical Trial registry ChiCTR2200060117. Registered on 19 May, 2022.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Wang Y, Yuan H, Jiang R, et al. Effects of soluble dietary fiber on glycolipid metabolism in gestational diabetes mellitus: study protocol for a randomized controlled clinical trial. Trials. 2025. PMID: 40993726. doi:10.1186/s13063-025-09080-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。